Status:
UNKNOWN
Ultra-wide-field Fluorescein Angiography in Patients With Retinal Vein Occlusion
Lead Sponsor:
Renmin Hospital of Wuhan University
Conditions:
Retinal Vein Occlusion
Eligibility:
All Genders
18+ years
Brief Summary
The changes of ischemic index and vascular leakage index, and the effect on macular edema and neovascularization in retinal vein occlusion by ultra-wide field fluorescence angiography (UWFA)
Detailed Description
In this study, the ischemic index and vascular leakage index, and the effect on macular edema and neovascularization in retinal vein occlusion will be evaluated by ultra-wide field fluorescence angiog...
Eligibility Criteria
Inclusion
- Male or female aged 18 years or more
- Patients with a diagnosis of CRVO,BRVO or HRVO without macular edema
- Duration of RVO not more than 4 months
- Naïve patients. Patient with previous RVO (more than 12 months before the inclusion date) which completely resolved (normalization of visual acuity and fundus examination) and who experienced a recurrence of RVO are also considered naive
- Patient who agrees to participate to the study and who has given his/her written, informed consent
Exclusion
- Patient with another retinal disease in the study eye: diabetic retinopathy, maculopathy of any cause (age-related macular degeneration, epimacular membrane, myopia, etc) responsible for decreased vision, advanced glaucoma, cataract severely affecting vision and/or requiring surgical treatment during the 24 months study period
- Active or suspected ocular or periocular infection
- Active severe intraocular inflammation
- RVO complicated with neovascularization
- Patient who has previously undergone laser panretinal photocoagulation, grid-laser or photodynamic therapy, any anti-VEGF or corticoids intravitreal injections in the study eye
- Patient already included in the study for the treatment of the fellow eye
- Pregnant or breastfeeding woman
- Lack of effective contraception for women of childbearing age
- Patient taking part in an interventional study
Key Trial Info
Start Date :
September 18 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 12 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04075695
Start Date
September 18 2019
End Date
August 12 2025
Last Update
October 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Renmin Hospital of Wuhan University
Wuhan, Hubei, China, 430000